To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC.
Clinical trial NCT02249650 · COMPLETED
Trial details
- NCT number
- NCT02249650
- Sponsor
- Taiwan Sunpan Biotechnology Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2020-02-12
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.